1. Home
  2. FBRX vs CIK Comparison

FBRX vs CIK Comparison

Compare FBRX & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBRX
  • CIK
  • Stock Information
  • Founded
  • FBRX N/A
  • CIK 1987
  • Country
  • FBRX United States
  • CIK United States
  • Employees
  • FBRX N/A
  • CIK N/A
  • Industry
  • FBRX Biotechnology: Pharmaceutical Preparations
  • CIK Finance/Investors Services
  • Sector
  • FBRX Health Care
  • CIK Finance
  • Exchange
  • FBRX Nasdaq
  • CIK Nasdaq
  • Market Cap
  • FBRX 154.5M
  • CIK 154.6M
  • IPO Year
  • FBRX N/A
  • CIK N/A
  • Fundamental
  • Price
  • FBRX $11.60
  • CIK $2.95
  • Analyst Decision
  • FBRX Strong Buy
  • CIK
  • Analyst Count
  • FBRX 2
  • CIK 0
  • Target Price
  • FBRX $61.00
  • CIK N/A
  • AVG Volume (30 Days)
  • FBRX 73.6K
  • CIK 115.4K
  • Earning Date
  • FBRX 08-13-2025
  • CIK 01-01-0001
  • Dividend Yield
  • FBRX N/A
  • CIK 9.03%
  • EPS Growth
  • FBRX N/A
  • CIK N/A
  • EPS
  • FBRX N/A
  • CIK N/A
  • Revenue
  • FBRX N/A
  • CIK N/A
  • Revenue This Year
  • FBRX N/A
  • CIK N/A
  • Revenue Next Year
  • FBRX N/A
  • CIK N/A
  • P/E Ratio
  • FBRX N/A
  • CIK N/A
  • Revenue Growth
  • FBRX N/A
  • CIK N/A
  • 52 Week Low
  • FBRX $4.11
  • CIK $2.50
  • 52 Week High
  • FBRX $28.68
  • CIK $3.19
  • Technical
  • Relative Strength Index (RSI)
  • FBRX 53.91
  • CIK 51.35
  • Support Level
  • FBRX $10.02
  • CIK $2.96
  • Resistance Level
  • FBRX $10.99
  • CIK $2.98
  • Average True Range (ATR)
  • FBRX 0.86
  • CIK 0.02
  • MACD
  • FBRX -0.06
  • CIK -0.01
  • Stochastic Oscillator
  • FBRX 60.78
  • CIK 31.25

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

Share on Social Networks: